Meningococcal serogroup A capsular polysaccharide — Drug Target

All drugs that target Meningococcal serogroup A capsular polysaccharide — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Meningococcal conjugate vaccine

Marketed (1)

• MCV-A vaccine · International Vaccine Institute · Meningococcal conjugate vaccine · Immunology
  MCV-A vaccine stimulates the immune system to produce antibodies and cellular immunity against meningococcal serogroup A polysaccharide capsule.